Artelo Biosciences (ARTL) vs Oragenics (OGEN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Oragenics is the larger company by market cap ($2.1 million vs $1.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARTL | OGEN |
|---|---|---|
| Share price | $3.37 | $0.463 |
| Market cap | $1.85M | $2.09M |
| 1-day change | -1.17% | -7.38% |
| EPS (TTM) | $-136.26 | $-2.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $179.19 | $1.45 |
| 52-week low | $3.33 | $0.46 |
| Distance from 52-week high | -98.12% | -68.07% |
| Average volume | 480.72K | 28.96K |
| Shares outstanding | 547.77K | 4.51M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ARTL vs OGEN FAQ
Which is bigger, Artelo Biosciences or Oragenics?
Oragenics (OGEN) is larger, with a market capitalization of $2.09M compared with $1.85M for Artelo Biosciences (ARTL).
Are Artelo Biosciences and Oragenics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.